Clinical Trials Update: July 10, 2007
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
181893
The U.S. Food and Drug  Administration on Thursday ordered the review of preventative  studies involving Pfizer Inc.'s painkillers Celebrex and  Bextra, in light of recent evidence they may increase the risk  of heart attack and stroke.
643185
FRIDAY, Sept. 15 (HealthDay News) -- Researchers may be able to determine the effectiveness of anti-angiogenic cancer drugs by measuring levels of a type of blood cell.
409638
Promising trials for a hepatitis C treatment bode well for the pharmaceutical.
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
266095
The pharmaceutical industry made a commitment Thursday to publish more data about clinical drug trials, amid growing questions about the safety of many leading companies' medicines.
362336
By Thomas Ginsberg, The Philadelphia Inquirer  Dec. 19--Wyeth Pharmaceuticals said today that the FDA has agreed to conduct a fast-track review of the company's new kidney cancer-fighting drug, Torisel.
335462
Description: A consortium of leading medical journals wants to prevent publication of clinical trial results that overemphasize positive data.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
727464
roundup Plus: Supercomputer center gets new No. 2...MIT, Caltech offer low-tech voting advice...Siemens builds phone to detect bad breath.
725261
There's encouraging news about an enzyme replacement drug.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
279186
WASHINGTON The first new cancer drug in ten years that is specifically designed to help children is a step closer to approval. An advisory panel at the Food and Drug Administration is recommending the use
438501
Here's what a newly approved drug looks like.
400180
Description: A new study finds that deaths in cancer drug trials have declined ten-fold, thanks to the development of drugs that are better targeted at the tumors themselves.
237569
Researchers are preparing for clinical trials examining whether high doses of vitamin C, administered intravenously, can slow the spread of non-Hodgkin's lymphoma.